J. Goldman & Co’s Compugen CGEN Stock Holding History

J. Goldman & Co’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-20,000	Closed	-$145K	–	271
2020 Q1	$145K	Buy	+20,000	New	+$157K	0.02%	221

Other funds holding CGEN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

J. Goldman & Co's CGEN Position: Q2 2020 in Review

J. Goldman & Co sold out of Compugen (CGEN) in Q2 2020, closing a stake of 20,000 shares — an estimated $145K sold.

J. Goldman & Co first reported a position in CGEN in Q1 2020 and held it in 1 quarter. The position peaked at $145K in Q1 2020. 91 funds tracked by Wall St. Rank hold CGEN as of Q2 2020.

J. Goldman & Co reported no remaining Compugen position as of Q2 2020 after selling out during the quarter.
J. Goldman & Co sold 20,000 Compugen shares in Q2 2020, an estimated $145K.
J. Goldman & Co first reported a position in Compugen in Q1 2020 and held it in 1 quarter.
J. Goldman & Co's Compugen position peaked at $145K in Q1 2020.
91 funds tracked by Wall St. Rank held Compugen as of Q2 2020.

Based on J. Goldman & Co's 13F filing for Q2 2020, filed 14 Aug 2020.